Zobrazeno 1 - 2
of 2
pro vyhledávání: '"M E Olmedo-García"'
Autor:
A Benito-Berlinches, A Soria-Rivas, Jorge Esteban-Villarrubia, A Cortés-Salgado, Y Lage-Alfranca, P Garrido-López, L Gorospe-Sarasua, P García-Abellás, A Gómez-Rueda, Javier Torres-Jiménez, M E Olmedo-García, P Gajate-Borau, E Corral-de la Fuente
Publikováno v:
Clinical and Translational Oncology. 23:1474-1480
Immune checkpoint inhibitors (ICI) have been associated with several immune-related adverse events, including sarcoidosis-like reactions (SLR). SLR, which has a low prevalence but an increasing incidence, is similar to sarcoidosis in terms of histolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::931dbb942ed1d1c396a7d61dd87e4f39
https://doi.org/10.1007/s12094-020-02546-w
https://doi.org/10.1007/s12094-020-02546-w
Autor:
J, Torres-Jiménez, J, Esteban-Villarrubia, P, García-Abellás, A, Cortés-Salgado, A, Soria-Rivas, P, Gajate-Borau, M E, Olmedo-García, E, Corral-de la Fuente, Y, Lage-Alfranca, A, Gómez-Rueda, A, Benito-Berlinches, L, Gorospe-Sarasua, P, Garrido-López
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 23(7)
Immune checkpoint inhibitors (ICI) have been associated with several immune-related adverse events, including sarcoidosis-like reactions (SLR). SLR, which has a low prevalence but an increasing incidence, is similar to sarcoidosis in terms of histolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0cdd9650a3a6785d266a463e96fad0a5
https://pubmed.ncbi.nlm.nih.gov/33433837
https://pubmed.ncbi.nlm.nih.gov/33433837